I agree, it makes sense to the accumulators, bless 'em.
The facts are that - apart from the Qty that's about to drop, the next few weeks shall also see the sp tagging some noticeable inflection points:
- Completion of Final pre-clinical Toxicology of PAT-DX1
- Completion of Master Cell Bank preparation of PAT-DX3.
- Completion of GMP Manufacturing process optimisation of PAT-DX3
IMO, completion of the above - which's already well underway - is the only thing holding BP from signing a deal.
Not Financial Advice DYOR
Ann: Patrys Receives R&D Tax Incentive Refund, page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
